Results 1 to 10 of about 14,618 (167)

Compliance of post-exposure prophylaxis (PEP) following animal bite in Indian population: A systematic review and meta-analysis

open access: yesJournal of Family Medicine and Primary Care
Rabies is a life-threatening zoonotic disease in India, leading to numerous fatalities annually. Despite the availability of effective post-exposure prophylaxis (PEP), compliance with completing the vaccination regimen remains low, impeding efforts to ...
Aninda Debnath   +5 more
doaj   +1 more source

Novel rabies vaccine candidates development based on pseudotyped lentiviral vectors with rabies virus glycoprotein.

open access: yesPLoS Neglected Tropical Diseases
Rabies, caused by the rabies virus (RABV), remains a global public health issue. Traditional inactivated rabies vaccines are costly, risky, and require multiple doses for post-exposure prophylaxis.
Lifang Shuai   +9 more
doaj   +1 more source

Rabies situation in the Moscow Oblast in 2011–2023 and the role of oral vaccination of wild carnivores against rabies

open access: yesВетеринария сегодня
Rabies is a zoonotic viral disease of all warm-blooded animals caused by a neurotropic virus, member of the Lyssavirus genus of the Rhabdoviridae family. About 59,000 people die from hydrophobia globally every year.
A. V. Paroshin   +3 more
doaj   +1 more source

Colloidal Manganese Salt Improves the Efficacy of Rabies Vaccines in Mice, Cats, and Dogs. [PDF]

open access: yesJ Virol, 2021
Wang Z   +8 more
europepmc   +1 more source

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine

open access: yesBulletin of the World Health Organization
Although the introduction of tissue culture vaccines for rabies has dramatically improved the immunogenicity and safety of rabies vaccines, they are often prohibitively expensive for developing countries.
D.J. Briggs   +6 more
doaj   +1 more source

The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study

open access: yesTravel Medicine and Infectious Disease
Background: The combination of passive immune agents (human rabies immune globulin (HRIG) and equine rabies antiserum (ERA)) with vaccines are effective measures for preventing the onset of rabies post exposure. However, ERA and HRIG have potential risks
Yin Yin   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy